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Purpose of the study
A peculiar HIV epidemic has evolved in Romania since
1990. HIV screening of TB patients is usual practice start-
ing from 1998. In comparison to national statistics, Galati
county has similar prevalence for HIV/AIDS (50/100,000
vs. 60/100,000) but higher for TB (163.7/100,000 vs.
110.1/100,000). The purpose of the study is to assess the
epidemiology and clinical characteristics of HIV tubercu-
losis co-infection (HIV/TB) in Galati, Romania.
Methods
The method used was a retrospective analysis study on
HIV/TB patients followed up for at least 12 months after
TB diagnostic in the Infectious Diseases Hospital, Galati,
during 1998–2008.
Summary of results
A number of 98 HIV/TB from 272 HIV cases was recorded.
The average yearly incidence of TB was over 30 times
higher in HIV-positive (5.2%) than in HIV-negative
patients and tends to grow. The general characteristics of
the patients are: male (57%), rural area (54%), median
age 12 [1; 57] on HIV diagnostic time and 14 years old [2;
57] on TB diagnostic time. HIV was acquired vertically
(11%), sexually (19%) or horizontally during early child-
hood (70%). 8% of cases had history of TB before 1998.
44% had TB as the primary AIDS-defining event; 26.5%
developed TB after HIV diagnosis. 45% cases had extra-
pulmonary TB involvement and are related to lower CD4
count (median 77/uL vs. 233/uL, p < 0.001), older age
(median 16.5 vs. 14, p = 0.002) and mortality rate (p <
0.001). 50% had microbiological criteria for TB diagnosis.
Rate of microbiological evidence is lower in primary than
in secondary pulmonary TB (OR = 120.75) and is related
to smaller age. 27% patients received antiretroviral treat-
ment (ARV) at the time of TB diagnosis and two devel-
oped TB as immune reconstruction event. Anti-TB
treatment was associated with ARV on 61% (20% PI and
41% INNRT). Progression of immunologic suppression
was recorded after TB in 41% patients. From 98 HIV/TB
patients, 67 were cured, 11 relapsed and 21 died. Risk of
death is related to severity of immunosuppression on TB
diagnostic time (median CD4 count 219 in survivors vs.
42 in dead, p < 0.001).
Conclusion
The conclusions of the study are: 1. HIV/TB co-infection
has high incidence, especially in adolescents, while HIV/
TB co-infection is diagnosed late and has a poor progno-
sis; 2. The risk factors for death in HIV/TB co-infection are
low CD4, extra-pulmonary involvement and older age; 3.
A new strategy for improvement of TB diagnosis in HIV
patients should allow earlier medical involvement in
order to decrease HIV-TB mortality in Galati, Romania.
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